1,709
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Antiproliferative activity, cell-cycle arrest, apoptotic induction and LC-HRMS/MS analyses of extracts from two Linum species

, , , , , & show all
Pages 1491-1501 | Received 25 Jan 2022, Accepted 11 Jul 2022, Published online: 09 Aug 2022

References

  • Abbas M, Saeed F, Anjum FM, Afzaal M, Tufail T, Bashir MS, Ishtiaq A, Hussain S, Suleria HAR. 2017. Natural polyphenols: an overview. Int J Food Prop. 20(8):1689–1699.
  • Akbari Asl E, Fallah Mehrabadi J, Afshar D, Noorbazargan H, Tahmasebi H, Rahimi A. 2018. Apoptotic effects of Linum album extracts on AGS human gastric adenocarcinoma cells and ZNF703 oncogene expression. Asian Pac J Cancer Prev. 19:2911–2916.
  • Alejandre-García I, Álvarez L, Cardoso-Taketa A, González-Maya L, Antúnez M, Salas-Vidal E, Díaz JF, Marquina-Bahena S, Villarreal ML. 2015. Cytotoxic activity and chemical composition of the root extract from the Mexican species Linum scabrellum: mechanism of action of the active compound 6- methoxypodophyllotoxin. Evid Based Complement Alternat Med. 2015:298463.
  • Amirghofran Z, Bahmani M, Azadmehr A, Javidnia K. 2006. Induction of apoptosis in leukemia cell lines by Linum persicum and Euphorbia cheiradenia. J Cancer Res Clin Oncol. 132(7):427–432.
  • An F, Yang G, Tian J, Wang S. 2012. Antioxidant effects of the orientin and vitexin in Trollius chinensis Bunge in d-galactose-aged mice. Neural Regen Res. 7(33):2565–2575.
  • Ayres DC, Loike JD. 1990. Lignans: chemical, biological and clinical properties. Cambridge (UK): Cambridge University Press.
  • Chidambara Murthy KN, Jayaprakasha GK, Kumar V, Rathore KS, Patil BS. 2011. Citrus limonin and its glucoside inhibit colon adenocarcinoma cell proliferation through apoptosis. J Agric Food Chem. 59(6):2314–2323.
  • Ganesan K, Xu B. 2017. Molecular targets of vitexin and isovitexin in cancer therapy: a critical review: anticancer mechanisms of vitexin and isovitexin. Ann N Y Acad Sci. 1401(1):102–113.
  • Ghobrial IM, Witzig TE, Adjei AA. 2005. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin. 55(3):178–194.
  • Gurumurthy S, Vasudevan KM, Rangnekar VM. 2001. Regulation of apoptosis in prostate cancer. Cancer Metastasis Rev. 20(3–4):225–243.
  • Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell. 100(1):57–70.
  • Hartwell JL. 1982. Plants used against cancer: a survey. Lawrence, MA: Quarterman Publications.
  • He M, Min JW, Kong WL, He XH, Li JX, Peng BW. 2016. A review on the pharmacological effects of vitexin and isovitexin. Fitoterapia. 115:74–85.
  • Huncharek M, McGarry R, Kupelnick B. 2001. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis. Anticancer Res. 21(1B):765–769.
  • Huntimer ED, Halaweish FT, Chase CCL. 2006. Proliferative activity of Echinacea angustifolia root extracts on cancer cells: interference with doxorubicin cytotoxicity. C&B. 3(6):695–703.
  • Ijaz S, Akhtar N, Khan MS, Hameed A, Irfan M, Arshad MA, Ali S, Asrar M. 2018. Plant derived anticancer agents: a green approach towards skin cancers. Biomed Pharmacother. 103:1643–1651.
  • Iwasaki T, Kondo K, Kuroda T, Moritani Y, Yamagata S, Sugiura M, Kikkawa H, Kaminuma O, Ikezawa K. 1996. Novel selective PDE IV inhibitors as antiasthmatic agents. Synthesis and biological activities of a series of 1-aryl-2,3-bis(hydroxymethyl)naphthalene lignans. J Med Chem. 39(14):2696–2704.
  • Jabir NR, Anwar K, Firoz CK, Oves M, Kamal MA, Tabrez S. 2018. An overview on the current status of cancer nanomedicines. Curr Med Res Opin. 34(5):911–921.
  • Kamal A, Srinivasa Reddy T, Polepalli S, Shalini N, Reddy VG, Subba Rao AV, Jain N, Shankaraiah N. 2014. Synthesis and biological evaluation of podophyllotoxin congeners as tubulin polymerization inhibitors. Bioorg Med Chem. 22(19):5466–5475.
  • Khan H. 2014. Medicinal plants in light of history: recognized therapeutic modality. J Evid Based Complementary Altern Med. 19(3):216–219.
  • Ku SK, Bae JS. 2016. Vicenin-2 and scolymoside inhibit high-glucose-induced vascular inflammation in vitro and in vivo. Can J Physiol Pharmacol. 94(3):287–295.
  • Lee H, Venkatarame Gowda Saralamma V, Kim S, Ha S, Raha S, Lee W, Kim E, Lee S, Heo J, Kim G. 2018. Pectolinarigenin induced cell cycle arrest, autophagy, and apoptosis in gastric cancer cell via PI3K/AKT/mTOR signaling pathway. Nutrients. 10(8):1043.
  • Lee SK, Nam KA, Heo YH. 2003. Cytotoxic activity and G2/M cell cycle arrest mediated by antofine, a phenanthroindolizidine alkaloid isolated from Cynanchum paniculatum. Planta Med. 69(1):21–25.
  • Liu X, Jiang Q, Liu H, Luo S. 2019. Vitexin induces apoptosis through mitochondrial pathway and PI3K/Akt/mTOR signaling in human non-small cell lung cancer A549 cells. Biol Res. 52(1):7.
  • Lowe SW, Lin AW. 2000. Apoptosis in cancer. Carcinogenesis. 21(3):485–495.
  • Mohammed MMD, Chen M, Zhai L, Ibrahim NA. 2010. The cytotoxic activity of Linum grandiflorum leaves. Eur J Chem. 1(2):110–114.
  • Mukherjee AK, Basu S, Sarkar N, Ghosh AC. 2001. Advances in cancer therapy with plant based natural products. Curr Med Chem. 8(12):1467–1486.
  • Nagaprashantha LD, Vatsyayan R, Singhal J, Fast S, Roby R, Awasthi S, Singhal SS. 2011. Anticancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer. Biochem Pharmacol. 82(9):1100–1109.
  • Newman DJ, Cragg GM. 2007. Natural products as sources of new drugs over the Last 25 Years. J Nat Prod. 70(3):461–477.
  • Newman DJ, Cragg GM, Snader KM. 2003. Natural products as sources of new drugs over the period 1981-2002. J Nat Prod. 66(7):1022–1037.
  • Ojima I. 2008. Modern natural products chemistry and drug discovery. J Med Chem. 51(9):2587–2588.
  • Otto T, Sicinski P. 2017. Cell cycle proteins as promising targets in cancer therapy. Nat Rev Cancer. 17(2):93–115.
  • Paier C, Maranhão SS, Carneiro TR, Lima LM, Rocha DD, Santos R, Farias KM, Moraes-Filho MO, Pessoa C. 2018. Natural products as new antimitotic compounds for anticancer drug development. Clinics. 73(suppl 1):e813s.
  • Park HS, Kim GY, Nam TJ, Deuk Kim N, Hyun Choi Y. 2011. Antiproliferative activity of fucoidan was associated with the induction of apoptosis and autophagy in AGS human gastric cancer cells. J Food Sci. 76(3):T77–T83.
  • Rogers CM. 1982. The systematics of Linum sect. Linopsis (Linaceae). Pl Syst Evol. 140(2-3):225–234.
  • Schulze-Bergkamen H, Krammer PH. 2004. Apoptosis in cancer-implications for therapy. Semin Oncol. 31(1):90–119.
  • Seyfried TN, Shelton LM. 2010. Cancer as a metabolic disease. Nutr Metab. 7:7.
  • Shibata MA, Hasegawa R, Kurata Y, Yamada M, Tamano S, Fukushima S. 1990. Bladder epithelial hyperplasia in F344 rats after intravesical instillation of the antitumor chemotherapeutic agents Adriamycin® and mitomycin C. Cancer Lett. 49(1):41–49.
  • Spatafora C, Tringali C. 2012. Natural-derived polyphenols as potential anticancer agents. Anticancer Agents Med Chem. 12(8):902–918.
  • Teles RHG, Moralles HF, Cominetti MR. 2018. Global trends in nanomedicine research on triple negative breast cancer: a bibliometric analysis. Int J Nanomed. 13:2321–2336.
  • Tsai YL, Chiu CC, Yi-Fu Chen J, Chan KC, Lin SD. 2012. Cytotoxic effects of Echinacea purpurea flower extracts and cichoric acid on human colon cancer cells through induction of apoptosis. J Ethnopharmacol. 143(3):914–919.
  • Vasilev N, Ebel R, Edrada R, Fuss E, Alfermann A, Ionkova I, Petrova A, Repplinger M, Schmidt T. 2008. Metabolic profiling of lignan variability in Linum species of Section Syllinum native to Bulgaria. Planta Med. 74(3):273–280.
  • Vermeulen K, Van Bockstaele DR, Berneman ZN. 2003. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer: cell cycle regulation and deregulation. Cell Prolif. 36(3):131–149.
  • Xiang P, He RW, Han YH, Sun HJ, Cui XY, Ma LQ. 2016. Mechanisms of housedust-induced toxicity in primary human corneal epithelial cells: oxidative stress, proinflammatory response and mitochondrial dysfunction. Environ Int. 89–90:30–37.
  • Yang D, Zhang X, Zhang W, Rengarajan T. 2018. Vicenin-2 inhibits Wnt/β-catenin signaling and induces apoptosis in HT-29 human colon cancer cell line. Drug Des Devel Ther. 12:1303–1310.
  • Zhang G, Li D, Chen H, Zhang J, Jin X. 2018. Vitexin induces G2/M-phase arrest and apoptosis via Akt/mTOR signaling pathway in human glioblastoma cells. Mol Med Rep. 17:4599–4604.
  • Zhou Y, Liu YE, Cao J, Zeng G, Shen C, Li Y, Zhou M, Chen Y, Pu W, Potters L, et al. 2009. Vitexins, nature-derived lignan compounds, induce apoptosis and suppress tumor growth. Clin Cancer Res. 15(16):5161–5169.
  • Zhong Z, Chen X, Tan W, Xu Z, Zhou K, Wu T, Cui L, Wang Y. 2011. Germacrone inhibits the proliferation of breast cancer cell lines by inducing cell cycle arrest and promoting apoptosis. Eur J Pharmacol. 667(1–3):50–55.
  • Zhu Q, Mao LN, Liu CP, Sun YH, Jiang B, Zhang W, Li JX. 2016. Antinociceptive effects of vitexin in a mouse model of postoperative pain. Sci Rep. 6:19266.
  • Zi CT, Yang L, Kong QH, Li HM, Yang XZ, Ding ZT, Jiang ZH, Hu JM, Zhou J. 2019. Glucoside derivatives of podophyllotoxin: synthesis, physicochemical properties, and cytotoxicity. DDDT. 13:3683–3692.
  • Zilla MK, Nayak D, Amin H, Nalli Y, Rah B, Chakraborty S, Kitchlu S, Goswami A, Ali A. 2014. 4′-Demethyl-deoxypodophyllotoxin glucoside isolated from Podophyllum hexandrum exhibits potential anticancer activities by altering Chk-2 signaling pathway in MCF-7 breast cancer cells. Chem Biol Interact. 224:100–107.